Corcept Therapeutics (CORT) Operating Leases (2019 - 2025)
Historic Operating Leases for Corcept Therapeutics (CORT) over the last 9 years, with Q3 2025 value amounting to $6.4 million.
- Corcept Therapeutics' Operating Leases fell 637.61% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year decrease of 637.61%. This contributed to the annual value of $6.1 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Corcept Therapeutics' Operating Leases is $6.4 million, which was down 637.61% from $6.6 million recorded in Q2 2025.
- Corcept Therapeutics' Operating Leases' 5-year high stood at $6.8 million during Q1 2025, with a 5-year trough of $76000.0 in Q1 2024.
- Its 4-year average for Operating Leases is $3.4 million, with a median of $2.5 million in 2022.
- In the last 5 years, Corcept Therapeutics' Operating Leases crashed by 8688.16% in 2023 and then surged by 889342.11% in 2025.
- Quarter analysis of 4 years shows Corcept Therapeutics' Operating Leases stood at $1.1 million in 2022, then tumbled by 80.31% to $225000.0 in 2023, then surged by 2614.22% to $6.1 million in 2024, then rose by 4.11% to $6.4 million in 2025.
- Its Operating Leases was $6.4 million in Q3 2025, compared to $6.6 million in Q2 2025 and $6.8 million in Q1 2025.